- Mersana Therapeutics (NASDAQ:MRSN): Q2 GAAP EPS of -$0.36 beats by $0.02.
- Revenue of $0.2M (-95.2% Y/Y) misses by $0.54M.
- Press Release
Mersana Therapeutics EPS beats by $0.02, misses on revenue
Recommended For You
More Trending News
About MRSN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MRSN | - | - |
Mersana Therapeutics, Inc. |